• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童肾病综合征的研究现状。

Current Understanding of Nephrotic Syndrome in Children.

机构信息

Department of Pediatrics, Wayne State University School of Medicine, 400 Mack Avenue, Suite 1 East, Detroit, MI 48201, USA.

American University of Beirut Medical Center, Beirut, Lebanon.

出版信息

Pediatr Clin North Am. 2022 Dec;69(6):1079-1098. doi: 10.1016/j.pcl.2022.08.002. Epub 2022 Oct 29.

DOI:10.1016/j.pcl.2022.08.002
PMID:36880923
Abstract

Nephrotic syndrome in children is mostly idiopathic in origin. About 90% of patients respond to corticosteroids; 80-90% have at least one relapse and 3-10% become corticosteroid resistant after the initial response. A kidney biopsy is seldom indicated for diagnosis except in patients with atypical presentation or corticosteroid resistance. For those in remission, the risk of relapse is reduced by the administration of daily low dose corticosteroids for 5-7 days at the onset of an upper respiratory infection. Some patients may continue having relapses through adult life. Many country-specific practice guidelines have been published, which are very similar with clinically insignificant differences.

摘要

儿童肾病综合征多为特发性。约 90%的患者对皮质类固醇有反应;80-90%的患者至少有一次复发,3-10%的患者在初始反应后对皮质类固醇耐药。肾活检除了在表现不典型或皮质类固醇耐药的患者中很少用于诊断。对于缓解的患者,在上呼吸道感染发作时,给予每日低剂量皮质类固醇 5-7 天,可以降低复发的风险。一些患者可能会在成年后继续复发。许多国家特有的实践指南已经发布,它们之间存在非常相似的临床差异。

相似文献

1
Current Understanding of Nephrotic Syndrome in Children.儿童肾病综合征的研究现状。
Pediatr Clin North Am. 2022 Dec;69(6):1079-1098. doi: 10.1016/j.pcl.2022.08.002. Epub 2022 Oct 29.
2
Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.每日低剂量泼尼松预防上呼吸道感染儿童中类固醇敏感型肾病综合征复发:PREDNOS2 RCT。
Health Technol Assess. 2022 Jan;26(3):1-94. doi: 10.3310/WTFC5658.
3
Interventions for idiopathic steroid-resistant nephrotic syndrome in children.儿童特发性类固醇抵抗性肾病综合征的干预措施。
Cochrane Database Syst Rev. 2019 Nov 21;2019(11):CD003594. doi: 10.1002/14651858.CD003594.pub6.
4
Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.类固醇敏感型肾病综合征:儿童免疫抑制治疗的循证更新
Arch Dis Child. 2016 Apr;101(4):404-8. doi: 10.1136/archdischild-2015-308924. Epub 2015 Aug 19.
5
Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial.评价在上呼吸道感染期间给予儿童每日低剂量泼尼松龙以预防复发型激素敏感型肾病综合征复发的效果:PREDNOS 2 随机临床试验。
JAMA Pediatr. 2022 Mar 1;176(3):236-243. doi: 10.1001/jamapediatrics.2021.5189.
6
Corticosteroid therapy for nephrotic syndrome in children.儿童肾病综合征的皮质类固醇疗法。
Cochrane Database Syst Rev. 2000(4):CD001533. doi: 10.1002/14651858.CD001533.
7
Corticosteroid therapy for nephrotic syndrome in children.儿童肾病综合征的皮质类固醇治疗
Cochrane Database Syst Rev. 2001(2):CD001533. doi: 10.1002/14651858.CD001533.
8
Nephrotic syndrome.肾病综合征
Pediatr Rev. 2015 Mar;36(3):117-25; quiz 126, 129. doi: 10.1542/pir.36-3-117.
9
Corticosteroid therapy for nephrotic syndrome in children.儿童肾病综合征的皮质类固醇治疗
Cochrane Database Syst Rev. 2004(2):CD001533. doi: 10.1002/14651858.CD001533.pub2.
10
Corticosteroid therapy for nephrotic syndrome in children.儿童肾病综合征的皮质类固醇治疗
Cochrane Database Syst Rev. 2003(1):CD001533. doi: 10.1002/14651858.CD001533.

引用本文的文献

1
Knowledge, Attitude, and Practice of Nurses in Preventing Complications in Patients with Nephrotic Syndrome: A Cross-Sectional Study.护士预防肾病综合征患者并发症的知识、态度和实践:一项横断面研究。
Ther Clin Risk Manag. 2025 Aug 27;21:1295-1305. doi: 10.2147/TCRM.S538455. eCollection 2025.
2
Nutritional management of pediatric nephrotic syndrome regarding oxidative stress and antioxidant balance.小儿肾病综合征在氧化应激和抗氧化平衡方面的营养管理
Front Immunol. 2025 May 1;16:1542735. doi: 10.3389/fimmu.2025.1542735. eCollection 2025.
3
Enzyme-activatable kidney-targeted dendrimer-drug conjugate for efficient childhood nephrotic syndrome therapy.
用于高效治疗儿童肾病综合征的酶激活型肾脏靶向树枝状大分子-药物偶联物
Theranostics. 2024 Oct 21;14(18):6991-7006. doi: 10.7150/thno.101606. eCollection 2024.
4
Drug-drug interaction between diltiazem and tacrolimus in relation to CYP3A5 genotype status in Chinese pediatric patients with nephrotic range proteinuria: a retrospective study.中国儿童肾病范围蛋白尿患者中地尔硫䓬与他克莫司的药物相互作用与CYP3A5基因分型状态的关系:一项回顾性研究
Front Pharmacol. 2024 Sep 3;15:1463595. doi: 10.3389/fphar.2024.1463595. eCollection 2024.
5
Clinicopathological Pattern of Renal Biopsies in Children with Nephrotic Syndrome.儿童肾病综合征肾活检的临床病理模式。
Clin Med Res. 2024 Jun;22(2):76-83. doi: 10.3121/cmr.2024.1917.
6
Network Pharmacology and Molecular Docking Validation to Explore the Pharmacological Mechanism of Zhuling Decoction against Nephrotic Syndrome.网络药理学和分子对接验证探索竹沥饮治疗肾病综合征的药理机制。
Curr Pharm Des. 2024;30(28):2244-2256. doi: 10.2174/0113816128305808240529115047.
7
Choroidal Vascularity Index and Choroidal Structural Changes in Children With Nephrotic Syndrome.儿童肾病综合征的脉络膜血管指数和脉络膜结构变化。
Transl Vis Sci Technol. 2024 Mar 1;13(3):18. doi: 10.1167/tvst.13.3.18.
8
Immunosuppressive agents for frequently relapsing/steroid-dependent nephrotic syndrome in children: a systematic review and network meta-analysis.儿童频繁复发/依赖类固醇的肾病综合征的免疫抑制剂:一项系统评价和网状Meta分析
Front Immunol. 2024 Feb 23;15:1310032. doi: 10.3389/fimmu.2024.1310032. eCollection 2024.
9
Burdens and Difficulties Experienced by Parental Caregivers of Children and Adolescents with Idiopathic Nephrotic Syndrome in Mainland China: A Qualitative Study.中国大陆儿童及青少年特发性肾病综合征患儿家长照顾者所经历的负担与困难:一项定性研究
J Multidiscip Healthc. 2023 Dec 2;16:3749-3759. doi: 10.2147/JMDH.S413677. eCollection 2023.
10
Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis.目前对局灶节段性肾小球硬化症中循环通透因子的分子机制的认识。
Front Immunol. 2023 Sep 19;14:1247606. doi: 10.3389/fimmu.2023.1247606. eCollection 2023.